Review
Open access
Aug 2026
Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential
Together, these advances position engineered superantigens as promising immune‐amplifying platforms with the potential to complement existing cancer immunotherapies and improve responses in poorly immunogenic tumors.
U. Y. Virk, H. A. Malik, M. Anwer et al.
· The FASEB Journal · 0 citations